Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> PFIZER Latest News

JUN 01, 2014 - Yahoo! News

A Must Read - Share

Study may open new options for younger women with breast cancer

By Julie Steenhuysen CHICAGO (Reuters) - The estrogen-blocking drug Aromasin worked better than the long-standing therapy tamoxifen at keeping cancers from returning in younger women with early stage breast cancer, a finding that may change the way the patients are treated, U.S. researchers said on Sunday. Aromasin, a drug developed by Pfizer Inc that is sold generically as exemestane, is in a class of treatments called aromatase inhibitors that are typically used in post-menopausal women with low levels of estrogen. The drugs have largely been off-limits for younger women with working ... Read More

Tags: Study may open new options for younger women with breast cancer,  Pfizer Latest News